Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37947094/
Cardiovascular-kidney-metabolic (CKM) syndrome is a novel construct recently defined by the American Heart Association in response to the high prevalence of metabolic and kidney disease. Epidemiological data demonstrate higher absolute...
The PREVENT equations assess 10- and 30-year cardiovascular disease risk, incorporating CKM syndrome predictors, kidney function, and social determinants of health to enhance primary prevention strategies for diverse populations.
Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37653361/
The guidelines released by the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) in 2022 and those released in 2021 by the European Society of Cardiology (ESC)...
The 2022 ACC/AHA/HFSA and 2021 ESC guidelines for heart failure align on key recommendations but differ due to timing; this review highlights differences to support evidence-based clinical decision-making.
Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2 - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38970586/
Comorbidities naturally clustered into 5 mutually exclusive groups in RELAX-AHF-2, showing variations in clinical outcomes. These data emphasize that the specific combination of comorbidities can influence adverse outcomes and treatment...
The study identified five multimorbidity groups in acute heart failure patients, highlighting distinct clinical outcomes and treatment responses, emphasizing the importance of comorbidity patterns in managing these patients.
Cardiorenal interactions in heart failure: insights from recent therapeutic advances - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37364186/
Heart failure is a syndrome that may develop when cardiovascular disease progresses or is insufficiently treated and associated with a poor quality of life, high mortality rates, and increased healthcare...
New therapies, including SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs, enhance cardiovascular and renal outcomes in high-risk patients with diabetes and heart failure, significantly improving patient management.
Feasibility of a digital palliative care intervention (Convoy-Pal) for older adults with heart failure and multiple chronic conditions and their caregivers: a waitlist randomized control trial
Source : https://pubmed.ncbi.nlm.nih.gov/39354453/
ClinicalTrials.gov Identifier NCT04779931. Date of registration: March 3, 2021.
The Convoy-Pal intervention demonstrated feasibility and potential benefits for heart failure patients and their caregivers, highlighting the need for digital tools that effectively integrate both parties in palliative care.